Avra Medical (OTC: AVMR) Fully autonomous robotic surgery technology

Barry Cohen, CEO, Avra Medical
Barry Cohen, CEO, Avra Medical








Avra Medical (OTC: AVMR) interview with Barry Cohen, CEO. Barry discusses the technology Avra is developing for fully autonomous robotic surgery. The company’s goal is to receive FDA approval and enter commercialization by 2020, with an initial focus on automated dermatological surgery procedures.


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.